Skip to main content

Closed

XNCR: Xencor, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-36.7% / yr

Operating margin-217.9%

ROIC-30.6%

Financially safe

Stretched

Debt / equity0.34×

Interest coverage-7.6×

Current ratio6.57×

Xencor, Inc.

XNCRNASDAQ Global Market·USD·Closed

Xencor, Inc.

XNCRNASDAQ·USD·Closed

$20.21

−5.96%

$20.21

−$1.28 (5.96%)

52W Range

90thpctl

Volume

1.41×avg

Mkt Cap

1.50BUSD

P/E

-8.8TTM

Div Yield

–ann

52W Range

90thpctl

Volume

1.41×avg

Market Cap

1.50BUSD

P/E Ratio

-8.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings